{
  "timestamp": "2025-05-01T00:18:09.885054",
  "questionnaire": "cleaned_questionnaire.txt",
  "conversation": [
    {
      "role": "assistant",
      "content": "Good morning. My name is Dr. Carter. I'm here to help assess your mental health using the DSM-5 Level 1 Cross-Cutting Symptom Measure\u2014Adult. This will help us understand your symptoms over the past two weeks. Your answers are confidential, and I'll ask 23 questions to guide our conversation. Let's start with the first question when you're ready."
    },
    {
      "role": "patient",
      "content": "Okay, I guess... I'll try to answer honestly. But I don't think it's that bad, really. Let's get this over with."
    },
    {
      "role": "assistant",
      "content": "1. Little interest or pleasure in doing things?"
    },
    {
      "role": "patient",
      "content": "Well, I mean, sometimes I don't feel like doing anything. But I don't know, it's not like I'm totally unmotivated all the time. Maybe just when I'm stressed?"
    },
    {
      "role": "assistant",
      "content": "2. Feeling down, depressed, or hopeless?"
    },
    {
      "role": "patient",
      "content": "Hmm. I guess I've felt low a few times, but I don't dwell on it. It's just part of life, right? I manage."
    },
    {
      "role": "assistant",
      "content": "3. Feeling more irritated, grouchy, or angry than usual?"
    },
    {
      "role": "patient",
      "content": "Yeah, maybe I snap a bit sometimes, but everyone gets that way. I don't go crazy or anything!"
    },
    {
      "role": "assistant",
      "content": "4. Sleeping less than usual, but still have a lot of energy?"
    },
    {
      "role": "patient",
      "content": "No, actually I usually crash after... you know, using. Wait, sometimes I stay up all night, but that's not the same."
    },
    {
      "role": "assistant",
      "content": "5. Starting lots of projects or doing more risky things than usual?"
    },
    {
      "role": "patient",
      "content": "Risky things? Not really. I'm just normal, I guess. Maybe I've taken some risks, but not more than others."
    },
    {
      "role": "assistant",
      "content": "6. Feeling nervous, anxious, or on edge?"
    },
    {
      "role": "patient",
      "content": "Yeah, all the time. But that's why I... you know, just relax sometimes. It's the anxiety that gets to me."
    },
    {
      "role": "assistant",
      "content": "7. Feeling panic or being frightened?"
    },
    {
      "role": "patient",
      "content": "Once or twice, maybe. But I don't have full-on panic attacks or anything. That's too much drama."
    },
    {
      "role": "assistant",
      "content": "8. Avoiding situations because of anxiety?"
    },
    {
      "role": "patient",
      "content": "Not exactly avoiding. I just... plan around things that stress me. It's not that bad!"
    },
    {
      "role": "assistant",
      "content": "9. Unexplained aches or pains?"
    },
    {
      "role": "patient",
      "content": "Hmm, sometimes my head or back aches. Probably from stress, not anything serious."
    },
    {
      "role": "assistant",
      "content": "10. Feeling your illnesses aren't taken seriously enough?"
    },
    {
      "role": "patient",
      "content": "Not really. I don't like going to doctors anyway."
    },
    {
      "role": "assistant",
      "content": "11. Thoughts of actually hurting yourself?"
    },
    {
      "role": "patient",
      "content": "Well, maybe once or twice I thought, 'What if...' but I wouldn't *do* anything. It's just... passing thoughts."
    },
    {
      "role": "assistant",
      "content": "\n<think>\nOkay, let's tackle this. The user provided a structured response based on the patient's answers to the DSM-5 questionnaire. The instructions are clear: follow the exact structure they specified, using the required tags and formatting.\n\nFirst, I need to start with a compassionate summary. I need to acknowledge the patient's struggles while showing empathy. The patient mentioned stress, anxiety, and substance use indirectly. I should mention their efforts to cope and validate their feelings without judgment.\n\nNext, the diagnosis section. Looking at the symptoms: anhedonia, low mood, irritability, anxiety, substance use references, and suicidal ideation. The DSM-5 guidelines mention that substance use disorder combines abuse and dependence. The patient's answers like \"using\" and risky behavior (Q5, Q6) suggest possible substance use. The suicidal thoughts in Q11 are a red flag.\n\nThe main diagnoses to consider are Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), and Substance Use Disorder (SUD). The patient's responses about substance use and the impact on sleep and mood point towards SUD. Since the DSM-5 combines abuse and dependence, and the symptoms meet criteria for SUD, that's a key point.\n\nThe reasoning section needs to link the symptoms to the diagnosis. The comorbidity of MDD, GAD, and SUD is common. The patient's minimization could indicate denial, which is typical in SUD. The suicidal thoughts are critical here, even if transient.\n\nNext steps should include:  \n1. Comprehensive assessment for SUD (DSM-5 criteria for substance use disorder need to be checked, like tolerance, withdrawal, etc.)  \n2. Suicide risk evaluation (given the thoughts mentioned in Q11)  \n3. Mental health evaluation for depression and anxiety.  \n4. Addressing substance use with a non-confrontational approach to avoid resistance.  \n5. Somatic symptoms could be linked to stress or substance effects, so medical evaluation is needed.  \n\nI need to use the tags properly: wrap medical terms in <med> tags, symptoms in <sym>, and quotes from the patient in <quote>. Make sure not to use any markdown, just the specified tags.\n\nCheck for any missed points: The patient's downplaying their issues and possible substance use is key. The DSM-5 mentions that SUD includes both abuse and dependence, so even if criteria aren't fully met, it's a concern. Somatic symptom disorder might be considered, but the symptoms here seem tied to anxiety or substance use, so maybe not primary.\n\nPutting it all together in the structure they requested. Make sure each section is correctly labeled with the asterisks, no extra lines, and tags applied correctly. Avoid listing other disorders unless supported. Focus on the primary concerns: depression, anxiety, SUD, and suicide risk.  \n\nDouble-check the instructions: use exactly the four sections, headings with **, proper tags, and no extra text. Ensure the diagnosis is the most fitting based on the responses. Since substance use is a major factor and the DSM-5 combines SUD, that should be part of the diagnosis along with possible depression and anxiety.\n\nFinal check for empathy in the summary, correct medical terms in tags, and clear next steps. Make sure not to mention any disorder not supported by the answers. Somatic Symptom Disorder is mentioned in the references, but the patient attributes aches to stress, not excessive worry about illness, so maybe not the primary diagnosis here.\n\nAlright, time to structure all this into the required format without markdown, just using the tags and sections precisely.\n</think>\n\n<sym>Anhedonia</sym>, <sym>low mood</sym>, and <sym>irritability</sym> were mentioned, though downplayed, alongside <sym>anxiety</sym> and <sym>transient suicidal thoughts</sym>. You\u2019ve described struggling with stress and using substances to cope, yet your efforts to \u201cmanage\u201d these challenges are clear. I see how the cycle of anxiety, substance use, and emotional pain might feel overwhelming, and I\u2019m here to support you in addressing this without judgment.  \n\n**Diagnosis:**  \n<med>Mood Disorder</med> with <med>anxiety features</med> and <med>Substance Use Disorder</med> (provisional, pending full assessment), with <sym>suicidal ideation</sym>  \n\n**Reasoning:**  \nThe presentation aligns with <med>MDD</med> given <sym>anhedonia</sym>, <sym>depressed mood</sym>, and <sym>suicidal ideation</sym>, though full criteria may require confirmation. <med>Generalized Anxiety Disorder</med> is plausible due to persistent <sym>nervousness</sym> and somatic symptoms. <med>Substance Use Disorder</med> is indicated by indirect references to substance use (e.g., \u201cusing\u201d to cope with anxiety/sleep, risky behavior), and physiological effects like insomnia). The <sym>suicidal ideation</sym> (Q11), <quote>\u201cpassing thoughts\u201d</quote>) requires urgent evaluation for intent/risk. Comorbidity between <med>SUD</med> and mood/anxiety disorders is common here.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Immediate**:  \n   - Assess <sym>suicidal ideation</sym> via structured interview (e.g., Columbia-Suicide Severity Rating Scale) to determine risk level.  \n   - Evaluate <med>Substance Use Disorder</med> using DSM-5 criteria, including substance type, frequency, and functional impact (e.g., tolerance, withdrawal).  \n\n2. **Comprehensive Assessment**:  \n   - Screen for <med>MDD</med> via PHQ-9 and <med>GAD</med> via GAD-7 to quantify severity.  \n   - Explore <sym>somatic complaints</sym> (aches/pains) with a medical consult to rule out physical causes (e.g., substance toxicity, electrolyte imbalance).  \n\n3. **Treatment Planning**:  \n   - Integrate <med>cognitive-behavioral therapy (CBT)</med> for <med>anxiety/depression</med> and <med>motivational interviewing</med> for <med>SUD</med> engagement.  \n   - Discuss <med>medication</med> (e g., SSRIs for mood/anxiety, if tolerated without contraindications with current substances.  \n   - Safety planning for <sym>suicidal ideation</sym> and harm reduction strategies for substance use.  \n\n4. **Collaborative Care**:  \n   - Coordinate with a psychiatrist for <med>SUD</med> management and medical review of substance-related health risks.  \n   - Engage in family or peer support groups to address isolation and reinforce coping skills.  \n\nThis approach balances urgency around substance use and suicide risk while addressing underlying mood/anxiety disturbances. Let\u2019s proceed step by step, starting with safety and clarity around your substance use.",
      "rag_usage": {
        "documents": [
          {
            "title": "APA_DSM-5-Substance-Use-Disorder.pdf",
            "score": 0.6982,
            "highlight": "Each specific sub - stance (other than caffeine, which cannot be diagnosed as a substance use disorder) is addressed as a separate use disorder (e.g., alcohol use disorder, stimulant use disorder, etc.), but nearly all substances are diagnosed based on the same overarching criteria.",
            "excerpt": "     Substance-Related and \nAddictive Disorders\nIn the fifth edition of the Diagnostic and Statistic...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"each\", \"which\", \"use\", and 7 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Sleep-Wake-Disorders.pdf",
            "score": 0.6618,
            "highlight": "Sleep-Wake Disorders In the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders  (DSM-5), sleep-wake  disorders encompass 10 conditions manifested by disturbed sleep and causing distress as well as im - pairment in daytime functioning.",
            "excerpt": "Sleep-Wake Disorders\nIn the fifth edition of the Diagnostic and Statistical Manual of Mental Disorde...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"functioning\", \"mental\", \"conditions\", and 4 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Somatic-Symptom-Disorder.pdf",
            "score": 0.6589,
            "highlight": "While DSM-IV was organized centrally around the concept of  medically unexplained symptoms, DSM-5 criteria instead emphasize the degree to which a patient \u2019s  thoughts, feelings and behaviors about their somatic symptoms are disproportionate or excessive.",
            "excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"which\", \"around\", \"criteria\", and 8 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Conduct-Disorder.pdf",
            "score": 0.6568,
            "highlight": "\u00a9 2013 American Psychiatric Association  2 \u2022 Somatic Symptom Disorder Order DSM-5 and DSM-5 Collection    at www.appi.org.",
            "excerpt": "and research of mental illnesses, including substance use disorders. Visit the APA at www.psychiatry...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"symptom\", \"psychiatric\", \"somatic\", and 2 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Disruptive-Mood-Disregulation-Disorder.pdf",
            "score": 0.6549,
            "highlight": "The unique features of DMDD necessitated a new diagnosis to ensure that children affected by this  disorder get the clinical help they need.",
            "excerpt": "ther disorders, such as depressive and anxiety disorders. \nThe unique features of DMDD necessitated ...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"they\", \"help\", \"clinical\", and 5 more matching aspects of your query."
          }
        ],
        "stats": {
          "query": "mental health diagnosis for patient with symptoms: \n<think>\nOkay, let's tackle this. The user provided a patient's responses to a DSM-5 Level 1 Cross-Cutting Symptom Measure. My job is to analyze these responses and structure the findings according to the five points listed. \n\nFirst, I need to read through each question and answer carefully. The patient's answers give clues about their mental state. Let's start with Q1 and A1: The patient starts off a bit resistant, saying they don't think it's that bad. That might indicate some denial or minimization of their symptoms.\n\nLooking at Q2 about lack of interest or pleasure, the patient says it's when they're stressed. So maybe their anhedonia is stress-related. They mention stress again in other answers, so that's a recurring theme. \n\nQ3 on feeling down or hopeless: They say they manage, which could imply some coping mechanisms, but also maybe underreporting severity. The response \"it's part of life\" might be a way to downplay the issue.\n\nQ4 asks about sleeping less but having energy. The patient mentions using, which could be substance use. They mention crashing and staying up all night, which might point to substance-induced sleep disturbances. I should note substance use as a possible issue here.\n\nQ5 about starting projects or risky behavior: They downplay it, but the note about \"maybe I've taken some risks\" is a red flag. The mention of risky things might hint at possible substance abuse or impulsive behavior.\n\nQ6 on nervousness or anxiety: They acknowledge being anxious all the time and using something to relax. The \"relax\" part could be substance use again. The answer to Q7 about panic also mentions anxiety leading to occasional panic but not full attacks. But the patient is using substances to cope with anxiety, which is significant.\n\nQ8 on avoiding situations due to anxiety: They say they plan around stressors but don't fully avoid. This could indicate some level of anxiety disorder, perhaps GAD, but not severe avoidance.\n\nQ9 on unexplained aches: They attribute to stress, which is common, but could also be a somatic symptom from anxiety or substance effects.\n\nQ10 on feeling illnesses aren't taken seriously: They dismiss this, which might mean they don't seek help often. That's a potential barrier to treatment.\n\nQ11 on suicidal thoughts: They have had passing thoughts but no intent. Still, any suicidal ideation needs attention, even if not active.\n\nNow, grouping these into the required sections. \n\nMain symptoms: Anhedonia when stressed, low mood, irritability, anxiety, possible substance use (since they mention \"using\" and needing to relax), and transient suicidal thoughts. The substance use is a key concern here because of the mentions of using and staying up all night.\n\nPatterns in responses: Minimization of symptoms (e.g., \"I don't think it's that bad\", \"not that bad\"), defensiveness when questioned about substance use, downplaying the severity (e.g., \"everyone gets that way\" for irritability).\n\nClinical significance: The anxiety and depression symptoms, possible substance use disorder (SUD), and the presence of suicidal ideation. The combination of anxiety, depression, and substance use could indicate co-occurring disorders. The substance use might be exacerbating symptoms.\n\nRisk factors: The suicidal thoughts, even if passing, are a risk. The substance use complicates things because it can interfere with treatment and increase risks like overdose or worsened mental health. The downplaying might indicate denial or avoidance of addressing the substance use, which is a risk factor in itself.\n\nPutting it all together, the summary should note the depressive symptoms (anhedonia, low mood), anxiety (persistent nervousness, panic), the substance use as a coping mechanism (which is a significant issue here), and the suicidal ideation. Also, the patterns of minimizing symptoms and possible substance dependence.\n\nI need to make sure to use clinical terms: anhedonia, dysphoric mood, irritability, generalized anxiety, possible substance use disorder, suicidal ideation without intent. Also mention the possible comorbidity between anxiety, depression, and SUD. The risk factors include the suicidal thoughts and the substance use which can increase risk of harm. The minimization is important because it might indicate resistance to treatment or underreporting.\n\nWait, in Q5, the patient says \"risky things\" but then says \"not more than others.\" Hmm, but the mention of starting projects might be part of hypomania, but combined with their substance use, maybe it's the substance causing that behavior. But the answer isn't clear. Alternatively, they might be engaging in risky behaviors related to substance abuse.\n\nAlso, in Q4, the mention of \"using\" when talking about sleep is a key point. The patient might be using substances (like stimulants or something) that cause insomnia. The \"using\" part is critical here. Need to note possible substance-induced symptoms.\n\nIn the summary, the key points are: depressive symptoms (1 and 2), anxiety (6,7,8,10), substance use (4,5,6, maybe 5 is risky behavior linked to use?), suicidal ideation (11). The patterns of minimization and defensiveness when questioned about substance use. The risk factors include substance use and SI. The clinical significance is the comorbid conditions and the need for SUD assessment.\n\nI should structure it under the five headings as specified. Make sure not to speculate beyond what's given. For example, the \"using\" is mentioned, so substance use is clear, but the exact substance isn't specified. However, it's enough to note substance use as a factor.\n\nAlso, the patient's responses about not avoiding situations but planning around stress might indicate some level of functioning, but the anxiety is still present. The aches and pains could be somatic symptoms of anxiety or substance effects.\n\nOkay, putting all that into the required sections concisely.\n</think>\n\n**Clinical Observation Summary**  \n\n**1. Main Symptoms/Concerns:**  \n- **Depressive symptoms:** Anhedonia (Q2), intermittent depressed mood (Q3), and transient suicidal ideation (Q11).  \n- **Anxiety symptoms:** Persistent nervousness (Q6), situational panic (Q7), and somatic complaints (Q9).  \n- **Substance use indicators:** Ambiguously referenced (e.g., \"using\" in Q4, sleep disturbances linked to substance use, and possible risk-taking behaviors (Q5.  \n- **Irritability** (Q4) and **functional impairment** hinted at via stress-related symptoms.  \n\n**2. Response Patterns:**  \n- **Minimization:** Downplays symptom severity (Q1, Q3, Q8) and deflects from substance use (Q4, Q5, Q6).  \n- **Defensive rationalization:** Attributes symptoms to \"stress\" (Q2, Q3, Q9) and dismisses concerns (e.g., \"not that bad\" [Q1, Q8]).  \n- **Ambiguity about substance use:** References to \"using\" (Q4, Q6) and \"relax\" (Q7) suggest substance use as a coping mechanism, but details are obscured.  \n\n**3. Potential Clinical Significance:**  \n- **Major Depressive Disorder (MDD):** Partial criteria met (anhedonia, low mood, suicidal ideation).  \n- **Generalized Anxiety Disorder (GAD):** Persistent anxiety, tension, and somatic symptoms.  \n- **Substance Use Disorder (SUD):** Indirect references to substance use, risky behaviors, and sleep disturbances (Q4, Q5, Q6).  \n- **Mixed/Comorbid presentation:** Interplay between anxiety, depression, and substance use.  \n\n**4. Risk Factors/Warning Signs:**  \n- **Suicidal ideation (Q11):** Transient but warrants further assessment for intent/planning.  \n- **Substance use:** Possible exacerbation of psychiatric symptoms, risk of escalation, and dependency.  \n- **Functional impairment:** Subtle hints of reduced motivation (Q2) and interpersonal tension (irritability, Q3).  \n\n**5. Summary (Clinical Language):**  \nThe patient presents with **depressive symptoms** (anhedonia, low mood) and **generalized anxiety** (persistent nervousness, somatic complaints), likely exacerbated by **substance use** (indirect endorsement of use linked to anxiety management and sleep disturbances). **Suicidal ideation** (transient, no intent explicitly stated) requires urgent evaluation. There is a pattern of **minimization of symptom severity** and **equivocal reporting of substance use**, suggesting possible denial or ambivalence about addressing this behavior. Comorbid SUD and mood/anxiety symptoms necessitate a comprehensive evaluation of substance-related etiology and risk. **Immediate priorities** include assessing SUD severity, suicidal ideation intent, and functional impact of comorbid conditions.",
          "results_count": 5,
          "requested_count": 5,
          "avg_score": 0.6661
        },
        "count": 5
      }
    }
  ],
  "diagnosis": "<sym>Anhedonia</sym>, <sym>low mood</sym>, and <sym>irritability</sym> were mentioned, though downplayed, alongside <sym>anxiety</sym> and <sym>transient suicidal thoughts</sym>. You\u2019ve described struggling with stress and using substances to cope, yet your efforts to \u201cmanage\u201d these challenges are clear. I see how the cycle of anxiety, substance use, and emotional pain might feel overwhelming, and I\u2019m here to support you in addressing this without judgment.  \n\n**Diagnosis:**  \n<med>Mood Disorder</med> with <med>anxiety features</med> and <med>Substance Use Disorder</med> (provisional, pending full assessment), with <sym>suicidal ideation</sym>  \n\n**Reasoning:**  \nThe presentation aligns with <med>MDD</med> given <sym>anhedonia</sym>, <sym>depressed mood</sym>, and <sym>suicidal ideation</sym>, though full criteria may require confirmation. <med>Generalized Anxiety Disorder</med> is plausible due to persistent <sym>nervousness</sym> and somatic symptoms. <med>Substance Use Disorder</med> is indicated by indirect references to substance use (e.g., \u201cusing\u201d to cope with anxiety/sleep, risky behavior), and physiological effects like insomnia). The <sym>suicidal ideation</sym> (Q11), <quote>\u201cpassing thoughts\u201d</quote>) requires urgent evaluation for intent/risk. Comorbidity between <med>SUD</med> and mood/anxiety disorders is common here.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Immediate**:  \n   - Assess <sym>suicidal ideation</sym> via structured interview (e.g., Columbia-Suicide Severity Rating Scale) to determine risk level.  \n   - Evaluate <med>Substance Use Disorder</med> using DSM-5 criteria, including substance type, frequency, and functional impact (e.g., tolerance, withdrawal).  \n\n2. **Comprehensive Assessment**:  \n   - Screen for <med>MDD</med> via PHQ-9 and <med>GAD</med> via GAD-7 to quantify severity.  \n   - Explore <sym>somatic complaints</sym> (aches/pains) with a medical consult to rule out physical causes (e.g., substance toxicity, electrolyte imbalance).  \n\n3. **Treatment Planning**:  \n   - Integrate <med>cognitive-behavioral therapy (CBT)</med> for <med>anxiety/depression</med> and <med>motivational interviewing</med> for <med>SUD</med> engagement.  \n   - Discuss <med>medication</med> (e g., SSRIs for mood/anxiety, if tolerated without contraindications with current substances.  \n   - Safety planning for <sym>suicidal ideation</sym> and harm reduction strategies for substance use.  \n\n4. **Collaborative Care**:  \n   - Coordinate with a psychiatrist for <med>SUD</med> management and medical review of substance-related health risks.  \n   - Engage in family or peer support groups to address isolation and reinforce coping skills.  \n\nThis approach balances urgency around substance use and suicide risk while addressing underlying mood/anxiety disturbances. Let\u2019s proceed step by step, starting with safety and clarity around your substance use.",
  "metadata": {
    "assistant_model": "qwen-qwq-32b",
    "patient_model": "qwen-qwq-32b",
    "patient_profile": "substance_abuse",
    "question_count": 23,
    "duration": 20306.33789205551,
    "full_conversation": true
  },
  "timing_metrics": {
    "conversation_generation_time": 11.0730881690979,
    "diagnosis_generation_time": 9.378877878189087,
    "rag_evaluation_time": 1.0967254638671875e-05,
    "total_time": 20.451985359191895
  },
  "rag_summary": {
    "total_rag_queries": 1,
    "total_documents_accessed": 5,
    "documents_accessed": {
      "APA_DSM-5-Substance-Use-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6982,
        "average_score": 0.6982,
        "example_excerpt": "     Substance-Related and \nAddictive Disorders\nIn the fifth edition of the Diagnostic and Statistic...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"each\", \"which\", \"use\", and 7 more matching aspects of your query."
      },
      "APA_DSM-5-Sleep-Wake-Disorders.pdf": {
        "access_count": 1,
        "highest_score": 0.6618,
        "average_score": 0.6618,
        "example_excerpt": "Sleep-Wake Disorders\nIn the fifth edition of the Diagnostic and Statistical Manual of Mental Disorde...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"functioning\", \"mental\", \"conditions\", and 4 more matching aspects of your query."
      },
      "APA_DSM-5-Somatic-Symptom-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6589,
        "average_score": 0.6589,
        "example_excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"which\", \"around\", \"criteria\", and 8 more matching aspects of your query."
      },
      "APA_DSM-5-Conduct-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6568,
        "average_score": 0.6568,
        "example_excerpt": "and research of mental illnesses, including substance use disorders. Visit the APA at www.psychiatry...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"symptom\", \"psychiatric\", \"somatic\", and 2 more matching aspects of your query."
      },
      "APA_DSM-5-Disruptive-Mood-Disregulation-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6549,
        "average_score": 0.6549,
        "example_excerpt": "ther disorders, such as depressive and anxiety disorders. \nThe unique features of DMDD necessitated ...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"they\", \"help\", \"clinical\", and 5 more matching aspects of your query."
      }
    },
    "rag_disabled": false,
    "evaluation_metrics": {
      "contextual_relevancy": {
        "average_score": null
      },
      "faithfulness": {
        "average_score": null
      },
      "answer_relevancy": {
        "average_score": null
      },
      "overall": {
        "average_score": null
      }
    }
  },
  "evaluation": {
    "timestamp": "2025-05-01 08:12:24",
    "provider": "groq",
    "model": "meta-llama/llama-4-scout-17b-16e-instruct",
    "llm_evaluation": {
      "timestamp": "2025-05-01 08:12:24",
      "model": "meta-llama/llama-4-scout-17b-16e-instruct",
      "rubric_scores": {
        "dsm_coverage": 4,
        "clinical_relevance": 4,
        "consistency": 4,
        "diagnostic_justification": 4,
        "empathy": 4
      },
      "explanations": {
        "dsm_coverage": "The therapist addressed most of the DSM-5 Level1 Cross-Cutting Symptom Measure domains, but some areas were not fully explored or required additional probing. Questions 1-11 and some parts of other domains were covered, but domains like psychosis (Q12-13), memory (Q15), repetitive thoughts/behaviors (Q16-17), dissociation (Q18), identity and relationships (Q19-20), and substance use (Q21-23) were either superficially addressed or not directly asked. For example, the therapist did not directly inquire about psychotic symptoms or detailed substance use patterns.",
        "clinical_relevance": "The therapist's questions generally aligned with DSM-5 criteria, but there were instances of slight inaccuracies or vague phrasing. For example, when asking about 'using' to cope with anxiety/sleep, the term was not clarified, which could lead to ambiguity. Additionally, some questions were phrased in a way that might not precisely capture the DSM-5 definitions, such as not directly asking about the frequency or amount of substance use.",
        "consistency": "The dialogue generally flows logically, with each question building on previous responses. However, there were minor logical inconsistencies, such as abrupt transitions between topics (e.g., moving from anxiety to substance use without clear connection). The therapist mostly followed up on concerning disclosures, like suicidal ideation, but could have further explored some domains like substance use patterns.",
        "diagnostic_justification": "The diagnoses of Mood Disorder with anxiety features and Substance Use Disorder (provisional) generally align with the patient's responses. The therapist explicitly stated the reasoning behind each diagnostic decision, citing symptoms like anhedonia, depressed mood, and suicidal ideation. However, the justification could be more comprehensive, and alternative diagnoses like Generalized Anxiety Disorder were not thoroughly ruled out or discussed.",
        "empathy": "The therapist's responses mostly showed empathy and a natural conversational style, but there were minor moments that seemed slightly robotic or impersonal. The therapist acknowledged the patient's distress and provided a supportive tone, but could have shown more personalized engagement. For example, the therapist could have explored the patient's feelings about their substance use and its impact on their life in more depth."
      },
      "overall_comments": "The conversation demonstrated a good understanding of the DSM-5 Level1 Cross-Cutting Symptom Measure and addressed most domains. However, some areas required more depth, and minor issues with clinical relevance and consistency were noted. The therapist showed empathy and a professional tone, but could improve on personalized engagement and comprehensive diagnostic justification. Overall, the conversation was well-structured but could benefit from more detailed exploration of certain symptoms and clearer connections between topics.",
      "average_score": 4.0,
      "diagnosis_accuracy": {
        "matches_profile": true,
        "confidence": 4,
        "explanation": "The diagnosis explicitly mentions 'Substance Use Disorder' (provisional, pending full assessment) and references substance use as a coping mechanism for stress, anxiety, and sleep issues. This aligns with the expected profile of substance_abuse. The diagnosis also emphasizes the need for a comprehensive assessment of Substance Use Disorder using DSM-5 criteria, further indicating a focus on substance abuse.",
        "classification": "substance_abuse"
      },
      "diagnosis_classification": {
        "expected_profile": "substance_abuse",
        "classified_as": "substance_abuse",
        "match": true,
        "confidence": 4
      },
      "question_evaluation": {
        "total_questions": 0,
        "questions_asked": 0,
        "percentage_asked": 0,
        "quality_score": 0,
        "explanation": "Could not evaluate question coverage due to technical issues.",
        "question_analysis": []
      },
      "evaluation_time": 2.193356990814209
    },
    "extended_metrics": {
      "coherence": {
        "global_coherence": 0.53373131143249,
        "local_coherence": 0.5677845764469786,
        "window_coherence": 0.5797104452060512
      },
      "readability": {
        "flesch_kincaid_grade": 8.17,
        "gunning_fog_index": 4.35,
        "flesch_reading_ease": 55.51
      },
      "diversity": {
        "distinct_1": 0.48214285714285715,
        "distinct_2": 0.8614834673815907,
        "distinct_3": 0.9615384615384616
      }
    },
    "diagnosis_evaluation": {
      "expected": "substance_abuse",
      "predicted": "<sym>Anhedonia</sym>, <sym>low mood</sym>, and <sym>irritability</sym> were mentioned, though downplayed, alongside <sym>anxiety</sym> and <sym>transient suicidal thoughts</sym>. You\u2019ve described struggling with stress and using substances to cope, yet your efforts to \u201cmanage\u201d these challenges are clear. I see how the cycle of anxiety, substance use, and emotional pain might feel overwhelming, and I\u2019m here to support you in addressing this without judgment.  \n\n**Diagnosis:**  \n<med>Mood Disorder</med> with <med>anxiety features</med> and <med>Substance Use Disorder</med> (provisional, pending full assessment), with <sym>suicidal ideation</sym>  \n\n**Reasoning:**  \nThe presentation aligns with <med>MDD</med> given <sym>anhedonia</sym>, <sym>depressed mood</sym>, and <sym>suicidal ideation</sym>, though full criteria may require confirmation. <med>Generalized Anxiety Disorder</med> is plausible due to persistent <sym>nervousness</sym> and somatic symptoms. <med>Substance Use Disorder</med> is indicated by indirect references to substance use (e.g., \u201cusing\u201d to cope with anxiety/sleep, risky behavior), and physiological effects like insomnia). The <sym>suicidal ideation</sym> (Q11), <quote>\u201cpassing thoughts\u201d</quote>) requires urgent evaluation for intent/risk. Comorbidity between <med>SUD</med> and mood/anxiety disorders is common here.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Immediate**:  \n   - Assess <sym>suicidal ideation</sym> via structured interview (e.g., Columbia-Suicide Severity Rating Scale) to determine risk level.  \n   - Evaluate <med>Substance Use Disorder</med> using DSM-5 criteria, including substance type, frequency, and functional impact (e.g., tolerance, withdrawal).  \n\n2. **Comprehensive Assessment**:  \n   - Screen for <med>MDD</med> via PHQ-9 and <med>GAD</med> via GAD-7 to quantify severity.  \n   - Explore <sym>somatic complaints</sym> (aches/pains) with a medical consult to rule out physical causes (e.g., substance toxicity, electrolyte imbalance).  \n\n3. **Treatment Planning**:  \n   - Integrate <med>cognitive-behavioral therapy (CBT)</med> for <med>anxiety/depression</med> and <med>motivational interviewing</med> for <med>SUD</med> engagement.  \n   - Discuss <med>medication</med> (e g., SSRIs for mood/anxiety, if tolerated without contraindications with current substances.  \n   - Safety planning for <sym>suicidal ideation</sym> and harm reduction strategies for substance use.  \n\n4. **Collaborative Care**:  \n   - Coordinate with a psychiatrist for <med>SUD</med> management and medical review of substance-related health risks.  \n   - Engage in family or peer support groups to address isolation and reinforce coping skills.  \n\nThis approach balances urgency around substance use and suicide risk while addressing underlying mood/anxiety disturbances. Let\u2019s proceed step by step, starting with safety and clarity around your substance use.",
      "matches": false,
      "classification": "substance_abuse",
      "classification_confidence": 4
    }
  }
}